These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 19125550)
1. Case study of the effects of office-based generic drug sampling on antibiotic drug costs and first-line antibiotic prescribing ratios. Conklin MH; Culley EJ; O'Donnell J J Manag Care Pharm; 2009; 15(1):55-61. PubMed ID: 19125550 [TBL] [Abstract][Full Text] [Related]
2. Effects of a physician office generic drug sampling system on generic dispensing ratios and drug costs in a large managed care organization. Scott AB; Culley EJ; O'Donnell J J Manag Care Pharm; 2007 Jun; 13(5):412-9. PubMed ID: 17605512 [TBL] [Abstract][Full Text] [Related]
3. Resistance to in-office dispensing of generic antibiotic samples. Kogut SJ; Spooner LM J Manag Care Pharm; 2009; 15(1):62-5. PubMed ID: 19125551 [No Abstract] [Full Text] [Related]
4. The relationship of antidepressant prescribing concentration to treatment duration and cost. Hodgkin D; Merrick EL; Hiatt D J Ment Health Policy Econ; 2012 Mar; 15(1):3-11. PubMed ID: 22611088 [TBL] [Abstract][Full Text] [Related]
5. Addition of generic medication vouchers to a pharmacist academic detailing program: effects on the generic dispensing ratio in a physician-hospital organization. Bhargava V; Greg ME; Shields MC J Manag Care Pharm; 2010; 16(6):384-92. PubMed ID: 20635829 [TBL] [Abstract][Full Text] [Related]
6. Measuring economic impact of applying daily average consumption limits. Flavin BM; Nishida LM; Karbowicz SH; Renner ME; Leonard RJ J Manag Care Pharm; 2014 Feb; 20(2):159-64. PubMed ID: 24456317 [TBL] [Abstract][Full Text] [Related]
7. Comparison of mail-order with community pharmacy in plan sponsor cost and member cost in two large pharmacy benefit plans. Johnsrud M; Lawson KA; Shepherd MD J Manag Care Pharm; 2007 Mar; 13(2):122-34. PubMed ID: 17330973 [TBL] [Abstract][Full Text] [Related]
8. Effects of electronic prescribing on formulary compliance and generic drug utilization in the ambulatory care setting: a retrospective analysis of administrative claims data. Ross SM; Papshev D; Murphy EL; Sternberg DJ; Taylor J; Barg R J Manag Care Pharm; 2005 Jun; 11(5):410-5. PubMed ID: 15934800 [TBL] [Abstract][Full Text] [Related]
9. Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program. Jacobson Vann JC; Christofferson S; Humble CG; Wegner SE; Feaganes JR; Trygstad TK J Manag Care Pharm; 2010 May; 16(4):250-63. PubMed ID: 20433216 [TBL] [Abstract][Full Text] [Related]
10. Estimated cost savings associated with the transfer of office-administered specialty pharmaceuticals to a specialty pharmacy provider in a Medical Injectable Drug program. Baldini CG; Culley EJ J Manag Care Pharm; 2011; 17(1):51-9. PubMed ID: 21204590 [TBL] [Abstract][Full Text] [Related]
11. Pharmacy students teaching prescribers strategies to lower prescription drug costs for underserved patients. Stebbins MR; Frear ME; Cutler TW; Lightwood JM; Fingado AR; Lai CJ; Lipton HL J Manag Care Pharm; 2013 Sep; 19(7):534-41. PubMed ID: 23964614 [TBL] [Abstract][Full Text] [Related]
12. Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication? Tungol A; Starner CI; Gunderson BW; Schafer JA; Qiu Y; Gleason PP J Manag Care Pharm; 2012; 18(9):690-700. PubMed ID: 23206212 [TBL] [Abstract][Full Text] [Related]
13. [Prescription of generic drugs to privately insured persons]. Wild F Versicherungsmedizin; 2012 Dec; 64(4):190-2. PubMed ID: 23236709 [TBL] [Abstract][Full Text] [Related]
14. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan. Johnson JT; Neill KK; Davis DA J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697 [TBL] [Abstract][Full Text] [Related]
15. Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy. Yokoyama K; Yang W; Preblick R; Frech-Tamas F J Manag Care Pharm; 2007 Apr; 13(3):235-44. PubMed ID: 17407390 [TBL] [Abstract][Full Text] [Related]
16. Disclosure of industry payments to prescribers: industry payments might be a factor impacting generic drug prescribing. Qian J; Hansen RA; Surry D; Howard J; Kiptanui Z; Harris I Pharmacoepidemiol Drug Saf; 2017 Jul; 26(7):819-826. PubMed ID: 28485111 [TBL] [Abstract][Full Text] [Related]
17. Do doctors in dispensing practices with a financial conflict of interest prescribe more expensive drugs? A cross-sectional analysis of English primary care prescribing data. Goldacre B; Reynolds C; Powell-Smith A; Walker AJ; Yates TA; Croker R; Smeeth L BMJ Open; 2019 Feb; 9(2):e026886. PubMed ID: 30813120 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults. Pauly NJ; Brown JD J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965 [TBL] [Abstract][Full Text] [Related]
19. Prescription drug costs and the generic dispensing ratio. Liberman JN; Roebuck MC J Manag Care Pharm; 2010 Sep; 16(7):502-6. PubMed ID: 20726679 [TBL] [Abstract][Full Text] [Related]
20. A comparison of costs of Medicare Part D prescriptions dispensed at retail and mail order pharmacies. Carroll NV J Manag Care Spec Pharm; 2014 Sep; 20(9):959-67. PubMed ID: 25166295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]